BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 7783700)

  • 1. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors within the nephron.
    Coe FL; Nakagawa Y; Parks JH
    Am J Kidney Dis; 1991 Apr; 17(4):407-13. PubMed ID: 2008908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
    Mustafi D; Nakagawa Y
    Biochemistry; 1996 Nov; 35(47):14703-9. PubMed ID: 8942630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
    Nakagawa Y
    Keio J Med; 1997 Mar; 46(1):1-9. PubMed ID: 9095576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
    Lieske JC; Hammes MS; Toback FG
    Scanning Microsc; 1996; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells.
    Lieske JC; Deganello S
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S422-9. PubMed ID: 10541277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
    Asplin J; DeGanello S; Nakagawa YN; Coe FL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal epithelial cells constitutively produce a protein that blocks adhesion of crystals to their surface.
    Kumar V; Yu S; Farell G; Toback FG; Lieske JC
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F373-83. PubMed ID: 15100100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.